TITLE

BIGMAR GETS BRAZILIAN APPROVAL TO MARKET FLUOROURACIL

PUB. DATE
July 2000
SOURCE
Worldwide Biotech;Jul2000, Vol. 12 Issue 7, p6
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports that Bigmar Inc. has received approval from Brazil's Agencia Nacional de Vigilancia Sanitaria to market the drug 5-fluorouracil in Brazil.
ACCESSION #
3350546

 

Related Articles

  • Fluorouracil/cisplatin.  // Reactions Weekly;1/19/2013, Issue 1435, p14 

    The article describes the case of a 59-year-old man who developed dropped head syndrome while receiving chemotherapy with fluorouracil and cisplatin for stage III nasopharyngeal carcinoma.

  • Cetuximab may not improve FLOX performance in metastatic colorectal cancer.  // Hem/Onc Today;3/10/2011, Vol. 12 Issue 5, p24 

    The article discusses a study, led by Doctor Kjell Magne Tveit, which found that adding cetuximab to fluorouracil (5-FU), folinic acid plus oxaliplatin (FLOX) does not improve outcomes in patients with metastatic colorectal cancer.

  • Fluorouracil.  // Reactions Weekly;2/6/2010, Issue 1287, p21 

    The article describes the case of an older man who developed erythrodysaesthesia on his palms, soles and scrotum while receiving fluorouracil for colon cancer.

  • Fluorouracil.  // Reactions Weekly;10/9/2010, Issue 1322, p14 

    The article describes the case of two patients who developed hyperammonemic encephalopathy following fluorouracil therapy for advanced gastric cancer or metastatic pancreatic cancer.

  • Fluorouracil.  // Reactions Weekly;2/4/2012, Issue 1387, p18 

    The article describes the case of a 45-year-old man who developed colitis during treatment with fluorouracil for rectal adenocarcinoma.

  • Fluorouracil.  // Reactions Weekly;12/8/2012, Issue 1431, p20 

    The article describes the case of an 83-year-old man who developed coronary spasm during chemotherapy with fluorouracil to treat colon cancer.

  • Fluorouracil.  // Reactions Weekly;12/8/2012, Issue 1431, p21 

    The article describes the case of a 64-year-old woman who experienced severe systemic toxicity after topical occlusive therapy with fluorouracil for actinic keratoses and superficial squamous cell carcinomas.

  • Fluorouracil.  // Reactions Weekly;2/18/2012, Issue 1389, p25 

    The article describes the case of an 83-year-old man with actinic keratoses on his face who developed with marked left-sided lid retraction and ectropion involving the right eye, a month after receiving topical fluorouracil.

  • Fluorouracil.  // Reactions Weekly;2/18/2012, Issue 1389, p25 

    The article describes the case of a 65-year-old man with eyelid squamous cell carcinoma who developed mild to moderate irritation during the first two week of in situ application of five percent fluorouracil cream.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics